Recent Quotes (30 days)

You have no recent quotes
chg | %

Nextgen Biomed Ltd  

(Public, TLV:NXGN)   Watch this stock  
Find more results for NXGN
+1.10 (2.70%)
Aug 30 - Close
TLV data delayed by 20 mins - Disclaimer
Currency in ILA unless noted
Range 41.10 - 41.90
52 week 0.39 - 41.90
Open 40.80
Vol / Avg. 25,000.00/137,559.00
Mkt cap 4.95M*
P/E     -
Div/yield     -
EPS -0.98*
Shares 11.87M
Beta     -
Inst. own     -
Sep 16, 2015
Nextgen Biomed Ltd Extraordinary Shareholders Meeting - 2:00PM GMT+3 - Add to calendar

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -660.66% -210.51%
Return on average equity - -
Employees 187 -
CDP Score - -


+972-3-6070320 (Phone)
+972-3-6070323 (Fax)

Website links


Nextgen Biomed Ltd., formerly Sela Group.Com Ltd., is an Israel-based company. Previously, the Company provided training and services to the Israeli and global high technology sector, software development, digital hardware design, information security, management of computing systems, information technology (IT), personnel positioning, consultancy, outsourcing, Website casting and Website conferencing in Israel and abroad. The Company's clients included the Israeli Defense Ministry, Raphael, Elisra, Avirnaoutic Industry, Amdocs, BMC, Comverse, Texas Instruments, The National Israeli Electricity Company, General Health Services Company, Bank Leumi, Pelephone, EDS, NDS, ECI Telecom and others. Currently, Nextgen Biomed Ltd. via its subsidiary, Sindolor Medical Ltd., operates research and development of injection devices while reducing pain.

Officers and directors

Uri Ackerman Chief Executive Officer
Noa Shelach Chief Executive Officer
Age: 43
Shlomo Zakai Member of the Management Board
Meirav Ben Hur-Saban Director
Age: 37
Ron Bentsur Director
Age: 49
Itzhak Israel Director
Age: 36
Ofer Elsheich External Director
Age: 48
Sigal Grinboim External Director
Age: 49